Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 17/20 | 0.53 |
| ▸ | S1PR5 | Q9H228 | 13/20 | 0.53 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.53 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.44 |
| ▸ | LTK | P29376 | 1/20 | 0.42 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9108025 | 0.86 | S1PR1 (0.58) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL9107617 | 0.79 | S1PR1 (0.58) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL9109266 | 0.79 | S1PR1 (0.55) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL9111175 | 0.78 | S1PR1 (0.60) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL16341310 | 0.78 | S1PR1 (0.48) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL27942984 | 0.71 | S1PR1 (0.54) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL27938162 | 0.70 | S1PR1 (0.51) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL13415796 | 0.70 | S1PR1 (1.00) | S1PR1S1PR5S1PR4MAP4K4MINK1 | |
| SCHEMBL3043605 | 0.70 | S1PR5 (1.00) | S1PR1S1PR5S1PR4S1PR3 | |
| SCHEMBL9110235 | 0.69 | S1PR1 (0.54) | S1PR1S1PR5S1PR4MAP4K4MINK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2646023-B1 | NOVEL AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS | ALLERGAN INC (US) | 2015-01-07 | — | — | EP | claimed |